Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00715273 · ClinicalTrials.gov registry record · Phase 4
Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 217
- Enrollment target
NCT00715273 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 217 participants.
The verdict
NCT00715273, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 217 participants
- Enrollment target
Study Summary
Atherosclerosis is a condition that occurs when fatty deposits build up along the inner walls of arteries. This study will examine the effectiveness of a combination of cholesterol-lowering medications at decreasing the fat content of atherosclerotic deposits in people who have coronary artery disease or carotid artery disease.
Interventions
- DRUG Niacin
- DRUG Colesevelam
- DRUG Atorvastatin
- DRUG Placebo Niacin
- DRUG Placebo Colesevelam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2001-05-01 |
| Est. Completion | 2019-03-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00715273
The ClinicalTrials.gov registry entry for NCT00715273 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 217 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Niacin is the first listed.
NCT00715273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00715273 about?
NCT00715273 is a clinical study titled "Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication". Atherosclerosis is a condition that occurs when fatty deposits build up along the inner walls of arteries. This study will examine the effectiveness of a combination of cholesterol-lowering medications at decreasing the fat content of atherosclerotic deposits in people who have coronary artery disea...
What is the current status of trial NCT00715273?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 217 participants. The study started on 2001-05-01. Estimated completion is 2019-03-01.
What interventions are being tested in trial NCT00715273?
The interventions under investigation include: Niacin (DRUG), Colesevelam (DRUG), Atorvastatin (DRUG), Placebo Niacin (DRUG), Placebo Colesevelam (DRUG).
Who is sponsoring clinical trial NCT00715273?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.